What is it about?
The importance of including psychotherapy when administering psychedelic medicines in clinical settings.
Featured Image
Why is it important?
This will help ensure that psychedelic medicines are administered safely and effectively to patients and research subjects.
Perspectives
The co-authors on this paper all have extensive experience working with MDMA in clinical research, and we hope that we can share what we have learned about the importance of therapy as part of this treatment with a broader audience.
Michael Alpert
Beth Israel Deaconess Medical Center
Read the Original
This page is a summary of: Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary, American Journal of Psychiatry, January 2024, American Psychiatric Association,
DOI: 10.1176/appi.ajp.20230665.
You can read the full text:
Contributors
The following have contributed to this page
